Tea Tree Oil for Acne

Table of Contents

1. The Bassett 1990 Head-to-Head vs Benzoyl Peroxide Randomized Controlled Trial
2. The Enshaieh 2007 Placebo-Controlled Confirmation
3. Mechanism: Cutibacterium acnes Membrane Disruption
4. The Separate Anti-Inflammatory Effect
5. The 5% Gel as the Standard Formulation
6. Commercial 5% Tea Tree Acne Products
7. How Tea Tree Compares to Benzoyl Peroxide
8. How Tea Tree Compares to Topical Retinoids
9. How Tea Tree Oil Was Used in the Trials
10. Safety Facts: Swallowed Oil, Skin Allergy and Oxidized Oil
11. Key Research Papers
12. Connections
13. Featured Videos

The Bassett 1990 Head-to-Head vs Benzoyl Peroxide Randomized Controlled Trial

The Bassett, Pannowitz & Barnetson 1990 paper in the Medical Journal of Australia is the foundational clinical trial of tea tree oil for acne. It is the paper that took tea tree from folk remedy to dermatologically-credible therapy and established the comparative framework that all subsequent trials have followed.

The design: 124 patients aged 13–28 with mild-to-moderate acne (inflamed and non-inflamed lesion counts both eligible) were randomized in a single-blind parallel-group trial to one of two treatments:

• 5% tea tree oil in a water-based gel, applied to affected areas twice daily after washing
• 5% benzoyl peroxide in a water-based lotion, applied to affected areas twice daily after washing

Patients were assessed at monthly intervals over three months. Investigators counted both inflammatory lesions (papules, pustules) and non-inflammatory lesions (open and closed comedones). Side effects (scaling, dryness, redness, itching, stinging) were assessed at each visit.

Key results at three months:

• Lesion counts — both 5% tea tree oil and 5% benzoyl peroxide significantly reduced the number of inflamed and non-inflamed lesions (open and closed comedones)
• Onset of action — the onset of action of tea tree oil was slower than that of benzoyl peroxide
• Side effects — this is where the trial separated the two arms most clearly. Scaling, dryness, redness, and itching were reported by 79% of patients on benzoyl peroxide vs 44% of patients on tea tree. The benzoyl peroxide group had substantially more discontinuation due to intolerance.

The conclusion: both therapies significantly reduced acne lesion counts, and fewer side effects were experienced by patients treated with tea tree oil; the trade-off the trial showed was slower onset in exchange for less skin irritation.

Methodological limitations of the trial: single-blind (only the assessor blinded), modest sample size, only one tea tree concentration tested. But the head-to-head comparison against the dominant first-line topical therapy of the era, with positive findings, made it the citation-anchor for an entire literature.

Back to Table of Contents

The Enshaieh 2007 Placebo-Controlled Confirmation

The Enshaieh 2007 trial in the Indian Journal of Dermatology, Venereology and Leprology addressed an important methodological criticism of the Bassett trial: the absence of a placebo arm. A 5% vs 5% comparison establishes non-inferiority but cannot rule out that both treatments simply benefited from the regression-to-the-mean and Hawthorne effects that affect any acne trial without a vehicle control.

Enshaieh and colleagues randomized 60 patients with mild-to-moderate acne vulgaris to either 5% tea tree oil gel or a vehicle-matched placebo gel, applied twice daily for 45 days. The trial was double-blind. Primary outcomes were Total Acne Lesion Counts (TLC) and the Acne Severity Index (ASI).

Results at 45 days:

• Tea tree oil gel improved the total acne lesion count (TLC) and the acne severity index (ASI) significantly more than placebo — the authors report it was 3.55 times (TLC) and 5.75 times (ASI) more effective than placebo
• Side effects in the two groups were relatively similar and tolerable

The placebo comparison answered the main criticism of the Bassett trial — that both treatments might simply have benefited from a vehicle effect or a regression artifact — although the trial was small (60 patients) and short (45 days). This was the definitive evidence that the Bassett finding was real, not just a generic vehicle effect or a regression artifact. The Enshaieh trial is the second-most-cited tea tree acne paper in the literature.

A 2026 systematic review and meta-analysis (Ye and colleagues) pooled seven studies with 445 patients. Tea tree oil was associated with a reduction in acne severity compared with control groups (pooled odds ratio 0.74, 95% confidence interval 0.63–0.88). Side effects were mostly local and mild, and mild itching was less common with tea tree oil than with the comparison treatments. The authors describe the reduction as modest and call for larger, high-quality trials with standardized formulations and long-term follow-up.

Back to Table of Contents

Mechanism: Cutibacterium acnes Membrane Disruption

Acne vulgaris is driven by four interacting processes: excess sebum production stimulated by androgens, abnormal keratinization of the pilosebaceous follicle producing comedones, colonization and proliferation of Cutibacterium acnes (the gram-positive lipophilic bacterium previously called Propionibacterium acnes) within the comedo, and inflammation triggered by C. acnes-derived antigens and the host immune response.

Tea tree oil's antimicrobial mechanism, discussed in detail on the antimicrobial deep-dive, is membrane disruption by terpinen-4-ol and related monoterpenes. The Raman 1995 laboratory study found that tea tree oil, terpinen-4-ol, alpha-terpineol and alpha-pinene were all active against C. acnes (then called Propionibacterium acnes) and two staphylococci, while cineole was inactive. Alpha-terpineol had the lowest minimum inhibitory concentration (MIC) — it was more potent than terpinen-4-ol, which was in turn more potent than alpha-pinene — and the MICs of tea tree oil and terpinen-4-ol were lower for C. acnes than for the staphylococci. The authors concluded that terpinen-4-ol is not the sole active constituent of the oil.

The clinical implication is that a 5% topical tea tree application delivers approximately 16× the in vitro MIC against C. acnes at the application site. Even accounting for partial absorption into sebum and the difficulty of reaching bacteria deep within the comedo, this concentration ratio provides adequate margin for bactericidal effect.

The reasoning that a 5% topical tea tree application gives a wide margin over the MIC against C. acnes is a laboratory calculation; how much oil reaches bacteria deep within the comedo, after partial absorption into sebum, has not been measured in people.

A notable feature of the tea tree antimicrobial mechanism for acne specifically: C. acnes, like all bacteria, has a phospholipid membrane that terpinen-4-ol disrupts in laboratory studies. Because C. acnes is also lipophilic and partitions into sebum, the oil-soluble tea tree monoterpenes co-partition into the same sebaceous environment, achieving locally high concentrations at the site of bacterial growth. This is the proposed mechanistic reason tea tree oil works topically for acne — the active compounds concentrate where the pathogenic bacterium concentrates.

Back to Table of Contents

The Separate Anti-Inflammatory Effect

One clinical observation from the Bassett and Enshaieh trials — and from subsequent observational studies — is that tea tree oil reduces inflammatory acne lesions (papules and pustules) more effectively than would be predicted from antimicrobial activity alone. This led to investigation of a separate anti-inflammatory effect, distinct from the antimicrobial mechanism.

The Carson 2006 review summarized the anti-inflammatory data. Tea tree oil and its components show:

• In laboratory (cell) studies, suppression of tumor necrosis factor-alpha, interleukin-1, -8 and -10, and prostaglandin E2 production by activated human monocytes: the water-soluble part of tea tree oil cut tumor necrosis factor-alpha, interleukin-1 beta and interleukin-10 by about 50% and prostaglandin E2 by about 30%, and terpinen-4-ol alone also lowered interleukin-8 (Hart 2000)
• Suppression of histamine release from mast cells (which translates to reduced wheal-and-flare in cutaneous histamine challenge tests)
• Reduction of neutrophil chemotaxis
• Reduction of edema in standard carrageenan paw-edema rat models (a benchmark anti-inflammatory model)

For acne specifically, the inflammatory component is driven by the release of free fatty acids by C. acnes lipase activity (which provoke neutrophil chemotaxis), by release of bacterial cell-wall components that activate Toll-like receptors on resident macrophages, and by the subsequent release of pro-inflammatory cytokines. Tea tree's suppression of tumor necrosis factor-alpha, interleukin-1 and interleukin-8 in laboratory studies in particular bears on several of the key cytokines driving acne inflammation.

The therapeutic significance: tea tree oil acts on at least two of the four pathogenic processes in acne (the bacterial proliferation and the inflammation), whereas benzoyl peroxide acts primarily on the bacterial proliferation and only weakly on the inflammation. This may explain why the inflammatory lesion reduction was slightly better than expected from antimicrobial mechanism alone, and why tolerability is better than benzoyl peroxide (no oxidative skin irritation, plus an active anti-inflammatory contribution).

Back to Table of Contents

The 5% Gel as the Standard Formulation

The 5% topical concentration that emerged from the Bassett 1990 trial has remained the dominant commercial concentration for acne products for three decades. Pharmacologically the choice makes sense:

• 5% is well above the laboratory inhibitory concentration against C. acnes (a laboratory calculation), leaving margin for partial dilution by sebum and skin oils at the application site
• Tolerability data show that 5% produces minimal irritation in the majority of users; higher concentrations have been reported to cause more dryness and stinging, although a 20% gel was well tolerated in a small 2017 pilot study (below)
• Higher concentrations are needed for some indications (50–100% for nail fungus, 25% for tinea pedis) but acne does not require the deep tissue penetration that justifies high-concentration use

The vehicle matters as well. The Bassett trial used a water-based gel rather than an oil. Gel formulations have several advantages for acne use: they do not occlude follicles further, they wash off easily, they do not contribute additional sebaceous-zone oil that worsens comedone formation, and they accept water-soluble adjuvants (anti-inflammatory botanicals, mild astringents) that complement the tea tree active. Most commercial 5% tea tree acne products are water-based gels.

A 2017 Australian open-label pilot study (Malhi and colleagues) tested a stronger product: a 200 mg/g (20%) tea tree oil gel plus a 7 mg/g face wash, applied to the face twice daily for 12 weeks, with no comparison group. Of 18 people enrolled, 14 finished. Mean total lesion counts fell from 23.7 at the start to 17.2 at 4 weeks, 15.1 at 8 weeks and 10.7 at 12 weeks. There were no serious side effects; peeling, dryness and scaling occurred and cleared up without treatment.

Newer formulations have explored nanoemulsion delivery of tea tree oil combined with the topical retinoid adapalene. In a 2022 randomised trial (Najafi-Taher and colleagues), 100 patients used either a tea tree oil nanoemulsion gel containing adapalene or a marketed 0.1% adapalene gel once nightly for 12 weeks. The combination reduced total, inflammatory and non-inflammatory lesions significantly more than the adapalene gel; dryness, the most common side effect in both groups, was more frequent with the combination. The trial had no tea-tree-only group, so it does not show how tea tree oil alone compares. Tea tree may have a role as an adjunct to standard retinoid therapy rather than as a complete replacement. The tea tree trials described on this page enrolled people with mild-to-moderate acne.

Back to Table of Contents

Commercial 5% Tea Tree Acne Products

Over-the-counter tea tree acne products are sold at about the 5% concentration used in the Bassett trial, most often as water-based gels; compounding pharmacies can also prepare custom-concentration tea tree creams or gels.

Home preparation: tea tree essential oil diluted 1:20 (5 mL into 95 mL) in a non-comedogenic carrier (jojoba is the classic choice; sweet almond and fractionated coconut are also used) makes a 5% preparation. This is the cheaper route. Oil kept in amber glass away from heat and light oxidizes more slowly, and the oxidation products that build up in old oil are the main cause of allergic reactions (see the safety facts below). The DIY route saves money but requires care with measurement, storage, and shelf life (fresh oil only, replace within 12 months of opening, store in amber glass).

Back to Table of Contents

How Tea Tree Compares to Benzoyl Peroxide

The Bassett 1990 head-to-head trial remains the best direct comparison. Synthesizing the trial data with subsequent clinical experience:

• Efficacy — approximately equivalent at three months for mild-to-moderate acne. tea tree oil's onset of action was slower in the Bassett trial
• Tolerability — patients on tea tree oil had fewer side effects in the Bassett trial (the side effects assessed were scaling, dryness, redness, itching and stinging)
• Bleaching of fabrics — benzoyl peroxide bleaches towels, pillowcases, and clothing on contact. Tea tree does not
• Resistance — tea tree resistance in C. acnes has not been documented in clinical settings; C. acnes resistance to topical antibiotics (erythromycin, clindamycin) is common and rising. Benzoyl peroxide does not have meaningful resistance development
• Cost — both are inexpensive at the over-the-counter (OTC) level; tea tree may be more expensive per unit in some markets
• Combination use — practitioners describe alternating tea tree and benzoyl peroxide (one in the morning, the other at night) to combine the faster onset of benzoyl peroxide with the gentler profile of tea tree; this pattern was not tested in the trials above

In summary, the trials tested 5% tea tree gel in mild-to-moderate acne, where it reduced lesions with fewer side effects than benzoyl peroxide. Severe nodulocystic acne was not studied in these trials; for it, oral isotretinoin (see our Vitamin A skin page) is the standard of care.

The clinical bottom line: for mild-to-moderate inflammatory acne in a patient who has not tolerated benzoyl peroxide, 5% tea tree gel is a credible first-line alternative.

Back to Table of Contents

How Tea Tree Compares to Topical Retinoids

Topical retinoids (tretinoin, adapalene, tazarotene) work by a completely different mechanism than tea tree oil — they normalize keratinization of the follicular epithelium through retinoic acid receptor signaling, addressing the comedone-formation step of acne pathogenesis. They are particularly effective against non-inflammatory comedonal acne and against the underlying tendency to form new comedones.

Direct head-to-head trials of tea tree alone vs topical retinoids do not exist. The picture described in clinical practice (not from trials):

• Topical retinoids are superior to tea tree for purely comedonal (non-inflammatory) acne
• Tea tree is comparable to topical retinoids for purely inflammatory acne
• For mixed inflammatory and comedonal acne, a topical retinoid at night plus a 5% tea tree gel in the morning is described as addressing both pathogenic processes
• Some people with retinoid intolerance (severe dryness, peeling, irritation, which is common in the first 4–8 weeks of retinoid use) use tea tree gel as their primary therapy until retinoid tolerance develops, then add the retinoid back

The 2022 Najafi-Taher trial (100 patients, 12 weeks) found that a tea tree oil nanoemulsion gel containing adapalene reduced acne lesions more than a marketed adapalene gel, with more dryness; with no tea-tree-only group, it cannot separate the oil's own contribution. The two therapies address different pathogenic processes.

Back to Table of Contents

How Tea Tree Oil Was Used in the Trials

What the trials used, and what practitioners describe, for mild-to-moderate acne:

1. Patch testing — practitioners describe applying a small amount of 5% gel to the inner forearm and watching for 24 hours for redness, itching or stinging before facial use, because allergic reactions to tea tree oil occur (see the safety facts below)
2. Washing — in the Bassett trial the gel was applied after washing; vigorous scrubbing and harsh detergents are described as worsening acne by disrupting the skin barrier and triggering compensatory sebum production
3. Application — the Bassett trial applied 5% gel to affected areas twice daily after washing; the Malhi pilot applied a 20% gel and face wash to the face twice daily
4. Time to effect — tea tree oil's onset was slower than benzoyl peroxide's in the Bassett trial; the trials ran 45 days (Enshaieh), three months (Bassett) and 12 weeks (Malhi), and in the Malhi pilot lesion counts were still falling at 12 weeks
5. Combination with a retinoid — practitioners describe adding a topical retinoid (adapalene over-the-counter; tretinoin by prescription) at night when response is slow at 8 weeks, keeping tea tree in the morning; the 2022 Najafi-Taher trial used a combined tea tree–adapalene gel once nightly
6. Other acne contributors — high-glycemic diet, dairy intake (especially skim milk), inadequate sleep, and chronic stress are reported to worsen acne. See our Acne page for the broader picture
7. Severe acne — nodules, cysts and scarring were not part of these trials; oral prescription treatments (antibiotics, hormonal therapy, isotretinoin) are used for them

Back to Table of Contents

Safety Facts: Swallowed Oil, Skin Allergy and Oxidized Oil

• Swallowed tea tree oil is poisonous — the most important safety fact. Oral ingestion produces central nervous system (CNS) depression, ataxia, coma, and in severe cases respiratory failure. Pediatric ingestion cases have required intensive care. Tea tree oil is a topical-only product
• Pre-pubertal boys — breast growth (gynecomastia) concern — the Henley 2007 NEJM case series linked repeated topical use of products containing lavender and tea tree oils to prepubertal gynecomastia in three boys; it resolved after the products were stopped, and in human cell lines the oils showed estrogen-like and anti-androgen activity. A 2020 systematic review (Hawkins and colleagues) found four reports describing eleven children, judged the reporting of the cases insufficient, and did not find evidence to support the claim that tea tree essential oil is related to endocrine disruption in children; it notes that the concern remains among pediatric care providers and parents and that epidemiological research is needed
• Allergic contact dermatitis — tea tree oil is the most common essential oil cause of allergic contact dermatitis. The principal sensitizers are oxidation products that accumulate in old or improperly stored oil, not the parent monoterpenes. Oil kept in amber glass in cool, dark storage oxidizes more slowly; persistent redness or itching after use is the typical sign of a contact allergy
• Sun sensitivity — tea tree oil is not photosensitizing in the way that citrus essential oils are; topical retinoids, often used alongside it, carry label warnings about sun sensitivity
• Eyes — tea tree oil can produce severe irritation if it contacts the eye, including from oil left on the hands
• Pregnancy and breastfeeding — topical use at standard 5% concentrations on intact skin is generally considered acceptable but with limited evidence. Oil applied to the breast or nipple area during breastfeeding can be swallowed by the infant
• Pet safety — tea tree oil is significantly more toxic to cats and dogs than to humans

Back to Table of Contents

Key Research Papers

1. Bassett IB, Pannowitz DL, Barnetson RS (1990). A comparative study of tea-tree oil versus benzoylperoxide in the treatment of acne. Medical Journal of Australia 153(8):455-8. — PubMed PMID: 2145499
2. Enshaieh S, Jooya A, Siadat AH, Iraji F (2007). The efficacy of 5% topical tea tree oil gel in mild to moderate acne vulgaris: a randomized, double-blind placebo-controlled study. Indian Journal of Dermatology, Venereology and Leprology 73(1):22-5. — PubMed PMID: 17314442
3. Raman A, Weir U, Bloomfield SF (1995). Antimicrobial effects of tea-tree oil and its major components on Staphylococcus aureus, Staph. epidermidis and Propionibacterium acnes. Letters in Applied Microbiology 21(4):242-5. — PubMed PMID: 7576514
4. Hammer KA (2015). Treatment of acne with tea tree oil (melaleuca) products: a review of efficacy, tolerability and potential modes of action. International Journal of Antimicrobial Agents 45(2):106-10. — PubMed PMID: 25465857
5. Malhi HK, Tu J, Riley TV, Kumarasinghe SP, Hammer KA (2017). Tea tree oil gel for mild to moderate acne; a 12 week uncontrolled, open-label phase II pilot study. Australasian Journal of Dermatology 58(3):205-210. — PubMed PMID: 27000386
6. Najafi-Taher R, Jafarzadeh Kohneloo A, Eslami Farsani V, Mehdizade Rayeni N, Moghimi HR, Ehsani A, Amani A (2022). A topical gel of tea tree oil nanoemulsion containing adapalene versus adapalene marketed gel in patients with acne vulgaris: a randomized clinical trial. Archives of Dermatological Research 314(7):673-679. — PubMed PMID: 34251536
7. Carson CF, Hammer KA, Riley TV (2006). Melaleuca alternifolia (Tea Tree) oil: a review of antimicrobial and other medicinal properties. Clinical Microbiology Reviews 19(1):50-62. — PubMed PMID: 16418522
8. Brand C, Ferrante A, Prager RH, Riley TV, Carson CF, Finlay-Jones JJ, Hart PH (2001). The water-soluble components of the essential oil of Melaleuca alternifolia (tea tree oil) suppress the production of superoxide by human monocytes, but not neutrophils, activated in vitro. Inflammation Research 50(4):213-9. — PubMed PMID: 11392609
9. Hart PH, Brand C, Carson CF, Riley TV, Prager RH, Finlay-Jones JJ (2000). Terpinen-4-ol, the main component of the essential oil of Melaleuca alternifolia (tea tree oil), suppresses inflammatory mediator production by activated human monocytes. Inflammation Research 49(11):619-26. — PubMed PMID: 11131302
10. Koh KJ, Pearce AL, Marshman G, Finlay-Jones JJ, Hart PH (2002). Tea tree oil reduces histamine-induced skin inflammation. British Journal of Dermatology 147(6):1212-7. — PubMed PMID: 12452873
11. Henley DV, Lipson N, Korach KS, Bloch CA (2007). Prepubertal gynecomastia linked to lavender and tea tree oils. New England Journal of Medicine 356(5):479-85. — PubMed PMID: 17267908
12. Hammer KA, Carson CF, Riley TV, Nielsen JB (2006). A review of the toxicity of Melaleuca alternifolia (tea tree) oil. Food and Chemical Toxicology 44(5):616-25. — PubMed PMID: 16243420
13. Hawkins J, Hires C, Dunne E, Baker C (2020). The relationship between lavender and tea tree essential oils and pediatric endocrine disorders: A systematic review of the literature. Complementary Therapies in Medicine 49:102288. — PubMed PMID: 32147050
14. Ye Y, Lim JJ, Huang Z, Chew FT (2026). Efficacy and Safety of Melaleuca alternifolia (Tea Tree) Oil for Acne—A Systematic Review and Meta-Analysis. Phytotherapy Research 40(7):4444-4453. — PubMed PMID: 42098589

PubMed Topic Searches

1. PubMed: Tea tree oil acne vulgaris
2. PubMed: C. acnes and terpinen-4-ol
3. PubMed: Tea tree vs benzoyl peroxide
4. PubMed: Terpinen-4-ol anti-inflammatory
5. PubMed: 5% tea tree gel formulations

Back to Table of Contents

Connections

• All Herbs
• Tea Tree Overview
• Tea Tree Benefits Hub
• Tea Tree for Methicillin-Resistant Staphylococcus Aureus
• Tea Tree for Nail Fungus
• Tea Tree for Head Lice
• Acne
• Vitamin A for Skin (Retinoids)
• Vitamin A
• Zinc
• Manuka Honey
• Antibacterial Herbs
• Lavender
• Calendula
• Eczema
• Rosacea
• History

Back to Table of Contents

Featured Videos